"Fisher Scientists Discover Protein that Fuels Al..."

"Post-traumatic Stress Disorder in Veterans Linke..."

"New Alzheimer’s Brain Dye Shows Promise fo..."

"New Extended-Release Form of Namenda Is Approved..."

Text Size:

  • MAJOR BREAKTHROUGH

    Promising New Treatments Expected

    Nobel laureate, Dr. Paul Greengard and our Fisher scientists have published a new finding that is being hailed as a potential paradigm shift in how researchers around the world will fight Alzheimer’s disease.

    Read More...

  • Welcome

    Welcome to our newly redesigned website! Our redesign goal is to inform you about the latest, most accurate news on Alzheimer’s disease research, to offer information to help caregivers and to provide you with a comprehensive resource about this dreaded disease. Help us help you and please take a moment to complete our short survey so we can continue to improve our site and its information.

    Read More...

  • Resource Locator

    Find a doctor, facility, long-term care information, and more Alzheimer's and dementia resources in your area by zip code.

    Listings include phone numbers and directions...

    Locate Resources Near You »

  • Ask the Experts

    "What's the difference between dementia and Alzheimer's?"

    Our experts are here to give you a personal answer to your dementia and Alzheimer's questions. No question is too big or too small.

    Ask the Experts...

  • Clinical Stages of Alzheimer's

    Dr. Barry Reisberg was awarded a Life Time Achievement Award by the International Alzheimer's Association. He is author of the Clinical Stages of Alzheimer's, and defined the term Mild Cognitive Impairment. He helps his patients regain basic skill of living to prolong their independent, and ease the burden of caregivers.

    Read More...
"I've been diagnosed with Alzheimer's" "I'm caring for someone with Alzheimer's" "I'm here to make a difference" "What is the Fisher Center doing for me?"

Exciting Discoveries in Alzheimer’s Disease

The Fisher Center for Alzheimer’s Research Foundation primarily funds the research of Nobel laureate Dr. Paul Greengard. Dr. Greengard and his team of scientists have recently developed new technologies that will accelerate the pace of future Alzheimer’s research. Based on … Continue reading →

Our Alzheimer’s Disease Research

Our team of internationally renowned scientists, under the direction of Nobel laureate Dr. Paul Greengard, has been at the forefront of seminal research that has provided a conceptual framework for modern day investigations into Alzheimer’s disease. Our groundbreaking research is the … Continue reading →

Donate Online

Get Your Free copy of

Preserving Your
Memory Magazine

Preserving Your Memory magazine provides captivating, enlightening and entertaining articles about healthy aging vs. unhealthy aging.
Get Your Free Copy Now!

 

Expert Reviewed News

Fisher Scientists Discover Protein that Fuels Alzheimer’s Disease, Promising New Treatments Expected

September 1, 2010

Researchers at the Fisher Center for Alzheimer’s Disease Research laboratory published “Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer’s Disease” in Nature online on September 1, 2010.  Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates … Continue reading →

Post-traumatic Stress Disorder in Veterans Linked to Dementia

August 24, 2010

A growing number of veterans are returning from combat with post-traumatic stress disorder, or PTSD, and it may be increasing their risk of Alzheimer’s and other forms of dementia in old age, a new study shows. PTSD is a growing … Continue reading →

New Alzheimer’s Brain Dye Shows Promise for Early Diagnosis

August 24, 2010

A novel radioactive dye shows promise in detecting early brain changes in people with Alzheimer’s and could offer a new tool for diagnosing the disease at an early stage, when treatment may be most effective. The compound may also prove … Continue reading →

New Extended-Release Form of Namenda Is Approved

August 24, 2010

An extended-release form of Namenda, the drug used to treat moderate to severe Alzheimer’s disease, was approved by the US Food and Drug Administration. The approval clears the way for the drug to be sold in U.S. pharmacies. Namenda, also … Continue reading →

What Brain Scans and Gene Studies Can Teach Us About Alzheimer’s

August 24, 2010

Gene researchers have discovered several genes that may play a role in Alzheimer’s, and doctors who study the brain using imaging scans have identified changes in certain brain structures that may also be associated with the disease. Now, scientists have … Continue reading →

Toll Free: 1-800-ALZ0INFO or 1-800-259-4636      Email: info@alzinfo.org

This project was supported, in part, by a grant, number 90AZ2791, from the Administration on Aging, Department of Health and Human Services, Washington, D.C. 20201. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not, therefore, necessarily represent official Administration on Aging policy.